Page results
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
UCLH has declared a climate and health emergency, and has published a 10-point climate action plan to reach net zero carbon dioxide emissions by 2031.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Information about our UCLH Charity, charity funds and associated charities.
-
Having originally studied classics, and having first worked in publishing and in the British Library, I became a lawyer and spent ten years in commercial litigation practice in the City.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.
File results
-
FOI/2021/0468 - Patient data management system
-
FOI/2021/0475 - Covid-19 deaths
-
FOI/2021/0485 - Patient transport policy
-
FOI/2021/0490 - Greener NHS National Programme
-
FOI/2021/0494 - Maternity patients not eligible for free healthcare
-
FOI/2021/0499 - Cancer pathway started treatment
-
FOI/2021/0502 - Maternity and Neonates
-
FOI/2021/0507 - Data breaches - (2016 - 2021)
-
FOI/2021/0512 - Patient meals
-
FOI/2021/0514 - Mental health patients in ED